StockWatch
·
Pharmaceuticals
Quarterly Result5 Aug 2026, 04:17 pm

Neuland Labs Q1 FY27 Income at ₹650.1 Cr, EBITDA ₹231.1 Cr

AI Summary

Neuland Laboratories Limited announced its financial results for the quarter ended June 30, 2026. Total income for Q1 FY27 stood at ₹650.1 crore, a significant increase of 116.3% year-on-year from ₹300.6 crore in Q1 FY26. EBITDA surged by 448.2% to ₹231.1 crore from ₹42.1 crore in the prior year's quarter. Profit After Tax (PAT) also saw a substantial jump of 975.0% to ₹147.4 crore from ₹13.7 crore in Q1 FY26. The company's CEO highlighted encouraging performance from CMS & GDS businesses and strong customer conversations, with plans for increased investment based on available opportunities. An earnings call is scheduled for August 5, 2026.

Key Highlights

  • Total income grew 116.3% YoY to ₹650.1 crore in Q1 FY27.
  • EBITDA increased by 448.2% YoY to ₹231.1 crore.
  • PAT rose by 975.0% YoY to ₹147.4 crore.
  • CEO notes strong pipeline and increasing customer engagement.
  • Company plans further investment based on opportunities.